To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.
Clinical trial NCT00910871 · COMPLETED
Trial details
- NCT number
- NCT00910871
- Sponsor
- Janssen Infectious Diseases BVBA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-03-01
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.